FOIA
Response by FDA to KEI's FOIA Request Regarding the PSM India Summit of May 11, 2010 in New Delhi
Submitted by Anne Mira Guha on 19. October 2010 - 11:30In June of 2010, KEI was informed that representatives from the the United States Food and Drug Administration (FDA) had recently attended a summit in India on the issue of counterfeited and spurious medicines organized by the Partnership for Safe Medicines (PSM), a US-based organization with clear links to pharmaceutical corporate interests.
White House says ACTA text a State Secret. EU parliament says time for more transparency
Submitted by James Love on 12. March 2009 - 19:32On January 31, 2009, KEI submitted a Freedom of Information Act (FOIA) request to USTR for copies of seven documents containing much of the negotiating text of the proposed Anti-Counterfeiting Trade Agreement (ACTA). Today the White House office the United States Trade Representative denied the request, claiming the documents are “information that is properly classified in the interest of national security pursuant to Executive Order 12958.”
